BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20015567)

  • 1. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.
    Crotta S; Brazzoli M; Piccioli D; Valiante NM; Wack A
    J Hepatol; 2010 Feb; 52(2):183-90. PubMed ID: 20015567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.
    Tseng CT; Klimpel GR
    J Exp Med; 2002 Jan; 195(1):43-9. PubMed ID: 11781364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.
    Crotta S; Stilla A; Wack A; D'Andrea A; Nuti S; D'Oro U; Mosca M; Filliponi F; Brunetto RM; Bonino F; Abrignani S; Valiante NM
    J Exp Med; 2002 Jan; 195(1):35-41. PubMed ID: 11781363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.
    Yoon JC; Shiina M; Ahlenstiel G; Rehermann B
    Hepatology; 2009 Jan; 49(1):12-21. PubMed ID: 19085909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.
    Zhang S; Saha B; Kodys K; Szabo G
    J Hepatol; 2013 Sep; 59(3):442-9. PubMed ID: 23665181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
    Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
    PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.
    Keck ZY; Xia J; Cai Z; Li TK; Owsianka AM; Patel AH; Luo G; Foung SK
    J Virol; 2007 Jan; 81(2):1043-7. PubMed ID: 17079294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.
    Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD27 engagement by a soluble CD70 protein enhances non-cytolytic antiviral activity of CD56bright natural killer cells by IFN-γ secretion.
    Jang YS; Kang W; Chang DY; Sung PS; Park BC; Yoo SH; Park YW; Shin EC
    Clin Immunol; 2013 Dec; 149(3):379-87. PubMed ID: 24211844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
    Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
    J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.
    Yoon JC; Lim JB; Park JH; Lee JM
    J Virol; 2011 Dec; 85(23):12557-69. PubMed ID: 21937646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
    Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
    J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56
    Mele D; Mantovani S; Oliviero B; Grossi G; Lombardi A; Mondelli MU; Varchetta S
    J Hepatol; 2017 Dec; 67(6):1148-1156. PubMed ID: 28803951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
    Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
    J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
    Stegmann KA; Björkström NK; Ciesek S; Lunemann S; Jaroszewicz J; Wiegand J; Malinski P; Dustin LB; Rice CM; Manns MP; Pietschmann T; Cornberg M; Ljunggren HG; Wedemeyer H
    J Infect Dis; 2012 May; 205(9):1351-62. PubMed ID: 22457290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human type 2 myeloid dendritic cells produce interferon-λ and amplify interferon-α in response to hepatitis C virus infection.
    Zhang S; Kodys K; Li K; Szabo G
    Gastroenterology; 2013 Feb; 144(2):414-425.e7. PubMed ID: 23089201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    Yang CM; Yoon JC; Park JH; Lee JM
    PLoS One; 2017; 12(4):e0175793. PubMed ID: 28410411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.